YangXue QingNao Wan, a Compound Chinese Medicine, Attenuates Cerebrovascular Hyperpermeability and Neuron Injury in Spontaneously Hypertensive Rat: Effect and Mechanism

Objective The purpose of the study was to explore the effect of YangXue QingNao Wan (YXQNW), a compound Chinese medicine, on cerebrovascular hyperpermeability, neuronal injury, and related mechanisms in spontaneously hypertensive rat (SHR). Methods Fourteen-week-old male SHR were used, with Wistar Kyoto (WKY) rats as control. YXQNW (0.5 g/kg/day), enalapril (EN, 8 mg/kg/day), and nifedipine (NF, 7.1 mg/kg/day) were administrated orally for 4 weeks. To assess the effects of the YXQNW on blood pressure, the systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean blood pressure (MBP) were measured. After administering the drugs for 4 weeks, the cerebral blood flow (CBF), albumin leakage from microvessels in middle cerebral artery (MCA)-dominated area, and the number and morphology of microvessels were assessed in the hippocampus area and cortex. Neuronal damage and apoptosis were assessed by Nissl staining and TUNEL staining. To assess the mechanisms of cerebrovascular hyperpermeability, we performed immunofluorescence and Western blot to assess the expression and integrity of cerebral microvascular tight junction (TJ) and caveolin-1 (Cav-1) in cortex. Energy metabolism and Src-MLC-MLCK pathway in cortex were assessed then for elucidating the underlying mechanism of the observed effect of YXQNW. Results Spontaneously hypertensive rat exhibited higher blood pressure, Evans blue (EB) extravasation, albumin leakage, increased brain water content, decreased CBF, perivascular edema, and neuronal apoptosis in the hippocampus and cortex, all of which were attenuated by YXQNW treatment. YXQNW inhibited the downregulation of TJ proteins, mitochondrial Complex I, Complex II, and Complex V, and upregulation of caveolin-1, inhibiting Src/MLCK/MLC signaling in SHR. YXQNW combined with EN + NF revealed a better effect for some outcomes compared with either YXQNW or EN + NF alone. Conclusion The overall result shows the potential of YXQNW to attenuate blood–brain barrier (BBB) breakdown in SHR, which involves regulation of energy metabolism and Src/MLCK/MLC signaling. This result provides evidence supporting the application of YXQNW as an adjuvant management for hypertensive patients to prevent hypertensive encephalopathy.

[1]  Yu-ying Liu,et al.  Angioedema and Hemorrhage After 4.5-Hour tPA (Tissue-Type Plasminogen Activator) Thrombolysis Ameliorated by T541 via Restoring Brain Microvascular Integrity , 2018, Stroke.

[2]  Kai Sun,et al.  YangXue QingNao Wan and Silibinin Capsules, the Two Chinese Medicines, Attenuate Cognitive Impairment in Aged LDLR (+/-) Golden Syrian Hamsters Involving Protection of Blood Brain Barrier , 2018, Front. Physiol..

[3]  Yu-ying Liu,et al.  Bushen Huoxue Attenuates Diabetes-Induced Cognitive Impairment by Improvement of Cerebral Microcirculation: Involvement of RhoA/ROCK/moesin and Src Signaling Pathways , 2018, Front. Physiol..

[4]  Jie Zheng,et al.  Blood-Brain Barrier Disruption and Perivascular Beta-Amyloid Accumulation in the Brain of Aged Rats with Spontaneous Hypertension: Evaluation with Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2018, Korean journal of radiology.

[5]  H. Al‐Salami,et al.  Antihypertensive agents do not prevent blood–brain barrier dysfunction and cognitive deficits in dietary-induced obese mice , 2017, International Journal of Obesity.

[6]  Maurizio Galderisi,et al.  Erişkin hipertansiyonunda ekokardiyografi kullanimi özerine öneriler: Avrupa Kardiyovasköler Göröntöleme Birliǧi (EACVI) ve Amerikan Ekokardiyografi Derneǧi (ASE) raporu , 2016 .

[7]  Yuhua Fan,et al.  Tight junction disruption of blood–brain barrier in white matter lesions in chronic hypertensive rats , 2015, Neuroreport.

[8]  Kerang Zhang,et al.  Cerebralcare Granule® attenuates cognitive impairment in rats continuously overexpressing microRNA-30e , 2015, Molecular medicine reports.

[9]  J. Gottdiener,et al.  Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†. , 2015, European heart journal cardiovascular Imaging.

[10]  H. Vargas-Robles,et al.  The role of actin-binding proteins in the control of endothelial barrier integrity , 2014, Thrombosis and Haemostasis.

[11]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[12]  Kai Sun,et al.  Long-Term Stimulation with Electroacupuncture at DU20 and ST36 Rescues Hippocampal Neuron through Attenuating Cerebral Blood Flow in Spontaneously Hypertensive Rats , 2013, Evidence-based complementary and alternative medicine : eCAM.

[13]  S. Tayebati,et al.  Spontaneously hypertensive rat as a model of vascular brain disorder: Microanatomy, neurochemistry and behavior , 2012, Journal of the Neurological Sciences.

[14]  Yu-ying Liu,et al.  Cerebralcare Granule® attenuates blood–brain barrier disruption after middle cerebral artery occlusion in rats , 2012, Experimental Neurology.

[15]  Fang Wang,et al.  The Protective Effect of Cerebralcare Granule® on Brain Edema, Cerebral Microcirculatory Disturbance, and Neuron Injury in a Focal Cerebral Ischemia Rat Model , 2012, Microcirculation.

[16]  Kai Sun,et al.  Cerebralcare Granule, a Chinese herb compound preparation, improves cerebral microcirculatory disorder and hippocampal CA1 neuron injury in gerbils after ischemia-reperfusion. , 2010, Journal of ethnopharmacology.

[17]  K. Griendling,et al.  NADPH oxidases and angiotensin II receptor signaling , 2009, Molecular and Cellular Endocrinology.

[18]  F. Liao,et al.  The antioxidant Cerebralcare Granule attenuates cerebral microcirculatory disturbance during ischemia-reperfusion injury. , 2008, Shock.

[19]  S. Chrysant.  The Pathophysiologic Role of the Brain Renin‐Angiotensin System in Stroke Protection: Clinical Implications , 2007, Journal of clinical hypertension.

[20]  K. Takemori,et al.  Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function. , 2006, American journal of hypertension.

[21]  D. Gingras,et al.  Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase* , 2004, Journal of Biological Chemistry.

[22]  M. Ueno,et al.  Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats , 2004, Histochemistry and Cell Biology.

[23]  J. Santibañez,et al.  EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. , 2004, Experimental cell research.

[24]  A. Bresnick,et al.  Differential Regulation of Alternatively Spliced Endothelial Cell Myosin Light Chain Kinase Isoforms by p60Src * , 2001, The Journal of Biological Chemistry.

[25]  S. Liebner,et al.  Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood–brain barrier endothelial cells , 2000, Brain Research.

[26]  J. M. Burger,et al.  ATP depletion induces an increase in the assembly of a labile pool of polymerized actin in endothelial cells. , 1993, The American journal of physiology.

[27]  Heistad Dd,et al.  Protection of the blood-brain barrier during acute and chronic hypertension. , 1984 .

[28]  D. Heistad,et al.  Protection of the blood-brain barrier during acute and chronic hypertension. , 1984, Federation proceedings.

[29]  Y. Yamori,et al.  Increased transendothelial channel transport of cerebral capillary endothelium in stroke‐prone SHR. , 1983, Stroke.

[30]  K. Okamoto,et al.  CHANGES IN VASCULAR PERMEABILITY IN THE BRAIN OF STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS STUDIED WITH PEROXIDASE AS A TRACER , 1975 .